Aberrant expression of hormone receptors in adrenal Cushing's syndrome

Pituitary

Volumn 7, Issue 4, 2004, Pages 225-235

  Christopoulos, Stavroula ^a   Bourdeau, Isabelle ^a   Lacroix, André ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Aberrant receptor; ACTH independent macronodular adrenal hyperplasia (AIMAH); Adrenal adenoma; Adrenocortical hyperplasias; Cushing's syndrome; Ectopic receptor

Indexed keywords

1 [1 [4 (3 ACETAMIDOPROPOXY)BENZOYL] 4 PIPERIDYL] 1,2,3,4 TETRAHYDRO 2 QUINOLINONE; ANGIOTENSIN RECEPTOR; BETA ADRENERGIC RECEPTOR; CHORIONIC GONADOTROPIN RECEPTOR; G PROTEIN COUPLED RECEPTOR; GASTRIC INHIBITORY POLYPEPTIDE; HORMONE RECEPTOR; HYDROCORTISONE; LEUPRORELIN; LUTEINIZING HORMONE RECEPTOR; OCTREOTIDE; PROPRANOLOL; SEROTONIN RECEPTOR; VASOPRESSIN RECEPTOR;

ADRENAL CORTEX; ADRENAL CORTEX ADENOMA; ADRENAL HYPERPLASIA; ADRENALECTOMY; ARTICLE; CLINICAL PROTOCOL; CUSHING SYNDROME; HORMONAL REGULATION; HUMAN; HYDROCORTISONE RELEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BLOCKING; SCREENING TEST; STEROIDOGENESIS;

ADRENAL CORTEX; CUSHING SYNDROME; HUMANS; HYDROCORTISONE; RECEPTORS, ANGIOTENSIN; RECEPTORS, CATECHOLAMINE; RECEPTORS, CELL SURFACE; RECEPTORS, CORTICOTROPIN; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, GASTROINTESTINAL HORMONE; RECEPTORS, LH; RECEPTORS, SEROTONIN; RECEPTORS, VASOPRESSIN;

EID: 30944445062     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-005-1083-7     Document Type: Article

References (105)

1. Latronico AC, Chrousos GP. Extensive personal experience: Adrenocortical tumors. J Clin Endocrinol Metab 1997;82:1317-1324. 10.1210/jc.82.5.1317
2. Newell-Price J, Trainer P, Besser M, Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocr Rev 1998;19:647-672. 10.1210/er.19.5.647
3. LK Nieman 2000 Cushing's syndrome LJ Groot De JLe Jameson HG Burger Endocrinology 4 W. B. Saunders Co Philadephia 1691-1720
4. Bourdeau I, Stratakis CA. Cyclic AMP-dependent signaling aberrations in macronodular adrenal disease. Ann N Y Acad Sci 2002;968:240-255. 1:CAS:528:DC%2BD38XlvVSqsbw%3D
5. Shenker A, Laue L, Kosugi S, Merendino JJJ, Minegishi T, Cutler GBJ. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 1993;365:652-654. 10.1038/ 365652a0
6. Mauras N, Blizzard RM. The McCune-Albright syndrome. Acta Endocrinol Suppl (Copenh) 1986;279:207-217. 1:STN:280:BiiD2cvosFU%3D
7. Benjamin DR, McRoberts JW. Polyostotic fibrous dysplasia associated with Cushing syndrome. Arch Pathol 1973;96:175-3178. 1:STN:280:CSyB3s%2FgsVc%3D
8. Kirk JM, Brain CE, Carson DJ, Hyde JC, Grant DB. Cushing's syndrome caused by nodular adrenal hyperplasia in children with McCune-Albright syndrome. J Pediatr 1999;134:789-792. 1:STN:280:DyaK1M3osVOjug%3D%3D
9. Aarskog D, Tveteraas E. McCune-Albright's syndrome following adrenalectomy for Cushing's syndrome in infancy. J Pediatr 1968;73:89-96. 1:STN:280:CCeA3MzivVQ%3D
10. MacMahon HE. Albright's syndrome - thirty years later. (Polyostotic fibrous dysplasia). Pathol Annu 1971;6:81-146. 1:STN:280:CSyD3M7ivFA%3D
11. Danon M, Robboy SJ, Kim S, Scully R, Crawford JD. Cushing syndrome, sexual precocity, and polyostotic fibrous dysplasia (Albright syndrome) in infancy. J Pediatr 1975;87:917-921. 1:STN:280:CSmD2cjot1I%3D
12. Fragoso MC, Domenice S, Latronico AC, Martin RM, Pereira MA, Zerbini MC, et al. Cushing's syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene. J Clin Endocrinol Metab 2003;88:2147-2151. 10.1210/ jc.2002-021362
13. Skogseid B, Larsson C, Lindgren PG, Kvanta E, Rastad J, Theodorsson Wide L, et al. Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 1992;75:76-81. 10.1210/jc.75.1.76
14. Marchesa P, Fazio VW, Church JM, McGannon E. Adrenal masses in patients with familial adenomatous polyposis. Dis Colon Rectum 1997;40:1023-1028. 1:STN:280:ByiH3sfhsFA%3D
15. Yamakita N, Murai T, Ito Y, Miura K, Ikeda T, Miyamoto K, et al. Adrenocorticotropin-independent macronodular adrenocortical hyperplasia associated with multiple colon adenomas/carcinomas which showed a point mutation in the APC gene. Intern Med 1997;36:536-542. 1:CAS:528:DyaK2sXmt1yitrk%3D
16. Bourdeau I, Lacroix A. G-protein mutations (Gsα and G12α) are infrequent in the adrenal atissues with Cushing's syndrome secondary to ACTH-independent bilateral macronodular adrenal hyperplasia. The Endocrine Society 84th Meeting 2002;P1-385:244.
17. Swords FM, Noon LA, King PJ, Clark AJ. Constitutive activation of the human ACTH receptor resulting from a synergistic interaction between two naturally occurring missence mutations in the MC2R gene. Mol Cell Endocrinol 2004;213:149-154. 10.1016/j.mce.2003.10.052
18. Latronico AC, Reincke M, Mendonca BB, Arai K, Mora P, Allolio B, et al. No evidence for oncogenic mutations in the adrenocorticotropin receptor gene in human adrenocortical neoplasms. J Clin Endocrinol Metab 1995;80:875-877. 1:CAS:528:DyaK2MXktlOntLk%3D
19. Light K, Jenkins PJ, Weber A, Perrett C, Grossman A, Pistorello M, et al. Are activating mutations of the adrenocorticotropin receptor involved in adrenal cortical neoplasia? Life Sci 1995;56:1523-1527. 10.1016/0024-3205(95)00114-L
20. Schorr I, Ney RL. Abnormal hormone responses of an adrenocortical cancer adenyl cyclase. J Clin Invest 1971;50:1295-1300. 1:CAS:528:DyaE3MXktlSkurw%3D
21. Lacroix A, N'Diaye N, Tremblay J, Hamet P. Ectopic and Abnormal Hormone Receptors in Adrenal Cushing's Syndrome. Endocr Rev 2001;22:75-110. 10.1210/er.22.1.75
22. Lacroix A, Baldacchino V, Bourdeau I, Hamet P, Tremblay J. Cushing's syndrome variants secondary to aberrant hormone receptors. Trends Endocrinol Metab 2004;15:375-382. 1:CAS:528:DC%2BD2cXnslGjur4%3D
23. Hamet P, Larochelle P, Franks DJ, Cartier P, Bolte E. Cushing syndrome with food-dependent periodic hormonogenesis. Clin Invest Med 1987;10:530-533. 1:STN:280:BieC2M7ivVw%3D
24. Lacroix A, Bolte E, Tremblay J, Dupre J, Poitras P, Fournier H, et al. Gastric inhibitory polypeptide-dependent cortisol hypersecretion - a new cause of Cushing's syndrome. N Engl J Med 1992;327:974-980. 1:STN:280:By2A1M%2FgtFc%3D
25. Reznik Y, Allali-Zerah V, Chayvialle JA, Leroyer R, Leymarie P, Travert G, et al. Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. N Engl J Med 1992;327:981-986. 1:STN:280:By2A1M%2FgtFA%3D
26. N'Diaye N, Hamet P, Tremblay J, Boutin JM, Gaboury L, Lacroix A. Asynchronous development of bilateral nodular adrenal hyperplasia in gastric inhibitory polypeptide-dependent Cushing's syndrome. J Clin Endocrinol Metab 1999;84:2616-2622. 10.1210/jc.84.8.2616
27. Lebrethon MC, Avallet O, Reznik Y, Archambeaud F, Combes J, Usdin TB, et al. Food-dependent Cushing's syndrome: Characterization and functional role of gastric inhibitory polypeptide receptor in the adrenals of three patients. J Clin Endocrinol Metab 1998;83:4514-4519. 10.1210/ jc.83.12.4514
28. Pralong FP, Gomez F, Guillou L, Mosimann F, Franscella S, Gaillard RC. Food-dependent Cushing's syndrome: Possible involvement of leptin in cortisol hypersecretion. J Clin Endocrinol Metab 1999;84:3817-3822. 1:CAS:528:DyaK1MXms1Ogsr4%3D
29. Croughs RJ, Zelissen PM, Van Vroonhoven ThJ, Hofland LJ, N'Diaye N, Lacroix A, et al. GIP-dependent adrenal Cushing's syndrome with incomplete suppression of ACTH. Clin Endocrinol (Oxf) 2000;52:235-240. 10.1046/j.1365-2265.2000.00932.x
30. Gerl H, Rohde W, Biering H, Schulz N, Lochs H. [Food-dependent Cushing syndrome of long standing with mild clinical features]. Dtsch Med Wochenschr 2000;125:1565-1568. 10.1055/s-2000-9524
31. Groussin L, Perlemoine K, Contesse V, Lefebvre H, Tabarin A, Thieblot P, et al. The ectopic expression of the gastric inhibitory polypeptide receptor is frequent in adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia, but rare in unilateral tumors. J Clin Endocrinol Metab 2002;87:1980-1985. 1:CAS:528:DC%2BD38XjsFGhtrk%3D
32. de Herder WW, Hofland LJ, Usdin TB, de Jong FH, Uitterlinden P, van Koetsveld P, et al. Food-dependent Cushing's syndrome resulting from abundant expression of gastric inhibitory polypeptide receptors in adrenal adenoma cells. J Clin Endocrinol Metab 1996;81:3168-3172. 8784063
33. Chabre O, Liakos P, Vivier J, Chaffanjon P, Labat-Moleur F, Martinie M, et al. Cushing's syndrome due to a gastric inhibitory polypeptide-dependent adrenal adenoma: Insights into hormonal control of adrenocortical tumorigenesis. J Clin Endocrinol Metab 1998;83:3134-3143. 10.1210/jc.83.9.3134
34. Luton JP, Bertagna X. [Membrane receptors and endocrine tumors: Expression of vasopressin receptor V1 modulates the pharmacologic phenotype of adrenocortical tumors]. Bull Acad Natl Med 1998;182:299-309. 1:CAS:528:DyaK1cXks1Smtrg%3D
35. Tsagarakis S, Tsigos C, Vassiliou V, Tsiotra P, Pratsinis H, Kletsas D, et al. Food-dependent androgen and cortisol secretion by a gastric inhibitory polypeptide-receptor expressive adrenocortical adenoma leading to hirsutism and subclinical Cushing's syndrome: In vivo and in vitro studies. J Clin Endocrinol Metab 2001;86:583-589. 10.1210/ jc.86.2.583
36. N'Diaye N, Tremblay J, Hamet P, de Herder WW, Lacroix A. Adrenocortical overexpression of gastric inhibitory polypeptide receptor underlies food-dependent Cushing's syndrome. J Clin Endocrinol Metab 1998;83:2781-2785. 10.1210/jc.83.8.2781
37. Longo-Mazzuco T, Chabre O, Feige JJ, Thomas M. Démonstration du potentiel transformant du gène du récepteur du GIP dans les cellules du cortex surrénalien: Un pas vers l'étiologie du syndrome de Cushing lié à l'alimentation. Ann Endocrinol (Paris) 2004;65, C024:267.
38. Lacroix A, Tremblay J, Touyz RM, Deng LY, Lariviere R, Cusson JR, et al. Abnormal adrenal and vascular responses to vasopressin mediated by a V1- vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing's syndrome, and orthostatic hypotension. J Clin Endocrinol Metab 1997;82:2414-2422. 10.1210/ jc.82.8.2414
39. Horiba N, Suda T, Aiba M, Naruse M, Nomura K, Imamura M, et al. Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia. J Clin Endocrinol Metab 1995;80:2336-2341. 10.1210/jc.80.8.2336
40. Iida K, Kaji H, Matsumoto H, Okimura Y, Abe H, Fujisawa M, et al. Adrenocorticotrophin-independent macronodular adrenal hyperplasia in a patient with lysine vasopressin responsiveness but insensitivity to gastric inhibitory polypeptide. Clin Endocrinol (Oxf) 1997;47:739-745. 10.1046/j.1365-2265.1997.3011151.x
41. Demura R, Demura H, Nunokawa T, Baba H, Miura K. Responses of plasma ACTH, GH, LH and 11-hydroxycorticosteroids to various stimuli in patients with Cushing's syndrome. J Clin Endocrinol Metab 1972;34:852-859. 1:STN:280:CS2C3srjvVU%3D
42. Perraudin V, Delarue C, de Keyzer Y, Bertagna X, Kuhn JM, Contesse V, et al. Vasopressin-responsive adrenocortical tumor in a mild Cushing's syndrome: In vivo and in vitro studies. J Clin Endocrinol Metab 1995;80:2661-2667. 10.1210/jc.80.9.2661
43. Makino S, Hashimoto K, Sugiyama M, Hirasawa R, Takao T, Ota Z, et al. Cushing's syndrome due to huge nodular adrenocortical hyperplasia with fluctuation of urinary 17-OHCS excretion. Endocrinol Jpn 1989;36:655-663. 1:STN:280:By%2BC2M7ltl0%3D
44. Itagaki E, Nozaki M, Abe Y, Takizawa M, Furukawa H, Murakawa S. Direct effect of lysine-vasopressin on cortisol production in isolated adrenal cells from nodular adrenocortical hyperplasia. In: Mantero F, ed., Serono Symposia, New York: Raven Press, 1989;57:403-408.
45. Daidoh H, Morita H, Hanafusa J, Mune T, Murase H, Sato M, et al. In vivo and in vitro effects of AVP and V1a receptor antagonist on Cushing's syndrome due to ACTH-independent bilateral macronodular adrenocortical hyperplasia. Clin Endocrinol (Oxf) 1998;49:403-409. 10.1046/ j.1365-2265.1998.00490.x
46. Arnaldi G, Gasc JM, de Keyzer Y, Raffin-Sanson ML, Perraudin V, Kuhn JM, et al. Variable expression of the V1 vasopressin receptor modulates the phenotypic response of steroid-secreting adrenocortical tumors. J Clin Endocrinol Metab 1998;83:2029-2035. 10.1210/jc.83.6.2029
47. Mune T, Murase H, Yamakita N, Fukuda T, Murayama M, Miura A, et al. Eutopic overexpression of vasopressin V1a receptor in adrenocorticotropin-independent macronodular adrenal hyperplasia. J Clin Endocrinol Metab 2002;87:5706-5713. 10.1210/jc.2002-020067
48. Campbell KK, Baysdorfer C, Antonini S, Lacroix A. V1 vasopressin receptor sequence and expression in adrenal Cushing's syndrome with abberant response to vasopressin. The Endocrine Society's 86th Meeting, New Orleans, LO 2004;P3-416, 566.
49. Lee S, Jun S, Hong SW, Kim DJ, Rhee Y, Lim SK. Familial adrenocorticotropin-independent macronodular adrenal hyperplasia: Ectopic expression of vasopressin V1b, V2 receptors in the adrenal gland. The Endocrine Society's 86th Meeting, New Orleans, LO 2004;P3-417, 566.
50. Louiset E, Contesse V, Cartier D, Bertherat J, Duparc C, Barrande G, et al. Pharmacological profile and coupling mechanisms of illegitimate receptors in ACTH-independent macronodular bilateral adrenal hyperplasia causing Cushing's syndrome. The Endocrine Society's 86th Meeting, New Orleans LO 2004;P3-410, 564.
51. Matsukura S, Kakita T, Sueoka S, Yoshimi H, Hirata Y, Yokota M, et al. Multiple hormone receptors in the adenylate cyclase of human adrenocortical tumors. Cancer Res 1980;40:3768-3771. 1:STN:280:Bi6D28vktFA%3D
52. Hirata Y, Uchihashi M, Sueoka S, Matsukura S, Fujita T. Presence of ectopic beta-adrenergic receptors on human adrenocortical cortisol-producing adenomas. J Clin Endocrinol Metab 1981;53:953-957. 1:STN:280:Bi2D3s7itVw%3D
53. Katz MS, Kelly TM, Dax EM, Pineyro MA, Partilla JS, Gregerman RI. Ectopic beta-adrenergic receptors coupled to adenylate cyclase in human adrenocortical carcinomas. J Clin Endocrinol Metab 1985;60:900-909. 1:CAS:528:DyaL2MXktFOht7k%3D
54. Lacroix A, Tremblay J, Rousseau G, Bouvier M, Hamet P. Propranolol therapy for ectopic beta-adrenergic receptors in adrenal Cushing's syndrome. N Engl J Med 1997;337:1429-1434. 10.1056/NEJM199711133372004
55. Mircescu H, Jilwan J, N'Diaye N, Bourdeau I, Tremblay J, Hamet P, et al. Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing's syndrome? J Clin Endocrinol Metab 2000;85:3531-3536. 10.1210/jc.85.10.3531
56. Miyamura N, Tsutsumi A, Senokuchi H, Nakamaru K, Kawashima J, Sakai K, et al. A case of ACTH-independent macronodular adrenal hyperplasia: Simultaneous expression of several aberrant hormone receptors in the adrenal gland. Endocr J 2003;50:333-340. 10.1507/endocrj.50.333
57. Pignatelli D, Rodrigues E, Barbosa AM, Medina JL. Cushing syndrome due to the ectopic expression of adrenergic receptors in the adrenal cortex. A case of ACTH independent macronodular adrenal hyperplasia (AIMAH). The Endocrine Society's 86th Meeting, New Orleans, LO 2004;P3-592, 611.
58. Imohl M, Koditz R, Stachon A, Muller KM, Nicolas V, Pfeilschifter J, et al. [Catecholamine-dependent hereditary Cushing's syndrome - Follow-up after unilateral adrenalectomy]. Med Klin (Munich) 2002;97:747-753.
59. Mazzuco TL, Martinie M, Favre S, Bachelot I, Chabre O. ACTH-independent Cushing's Syndrome treated solely with propranolol therapy. The Endocrine Society 84th Meeting 2002;P25-2.
60. Sesmilo G, et al. Spanish Endocrine Society, Alicante, Spain. 2002.
61. Rao CV. The Beginning of a New Era in Reproductive Biology and Medicine: Expression of low levels of functional luteinizing hormone/human chorionic gonadotropin receptors in nongondal tissues. J Physiol Pharmacol 1996;47:41-53.
62. Pabon JE, Li X, Lei ZM, Sanfilippo JS, Yussman MA, Rao CV. Novel presence of luteinizing hormone/chorionic gonadotropin receptors in human adrenal glands. J Clin Endocrinol Metab 1996;81:2397-2400. 1:CAS:528:DyaK28XjsFykt7Y%3D
63. Seron-Ferre M, Lawrence CC, Jaffe RB. Role of hCG in regulation of the fetal zone of the human fetal adrenal gland. J Clin Endocrinol Metab 1978;46:834-837. 1:CAS:528:DyaE1cXksFOisb8%3D
64. Lacroix A, Hamet P, Boutin JM. Leuprolide acetate therapy in luteinizing hormone-dependent Cushing's syndrome. N Engl J Med 1999;341:1577-1581. 10.1056/NEJM199911183412104
65. N'Diaye N, Cartier D, Bourdeau I, Tremblay J, Hamet P, Lefebvre H, et al. Characterization of aberrant LH/hCG and serotonin 5-HT4 receptors in adrenal Cushing's syndrome. The 83rd Annual Meeting of the Endocrine Society, Denver, CO Abstract P1-407, 2001:235.
66. Feelders RA, Lamberts SW, Hofland LJ, van Koetsveld PM, Verhoef-Post M, Themmen AP, et al. Luteinizing hormone (LH)-responsive Cushing's syndrome: The demonstration of LH receptor messenger ribonucleic acid in hyperplastic adrenal cells, which respond to chorionic gonadotropin and serotonin agonists in vitro. J Clin Endocrinol Metab 2003;88:230-237. 10.1210/jc.2002-020621
67. Bourdeau I, D'Amour P, Hamet P, Boutin JM, Lacroix A. Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome. J Clin Endocrinol Metab 2001;86:5534-5540. 10.1210/jc.86.11.5534
68. Bertherat J, Barrande G, Lefebvre H, Raffin-Sanson ML, Bertagna X. Systematic screening confirms that illicit membrane receptors are frequent and often multiple in bilateral ACTH-independent macronodular adrenal hyperplasia (AIMAH). Program & Abstracts The Endocrine Society's 83rd Annual Meeting, Denver, CO 2001;Abstract P1-397, 233.
69. Goodarzi MO, Dawson DW, Li X, Lei Z, Shintaku P, Rao CV, et al. Virilization in bilateral macronodular adrenal hyperplasia controlled by luteinizing hormone. J Clin Endocrinol Metab 2003;88:73-77. 10.1210/ jc.2002-021292
70. Lefebvre H, Contesse V, Delarue C, Vaudry H, Kuhn JM. Serotonergic regulation of adrenocortical function. Horm Metab Res 1998;30:398-403. 1:CAS:528:DyaK1cXkt1Clsbs%3D
71. Cartier D, Lihrmann I, Parmentier F, Bastard C, Bertherat J, Caron P, et al. Overexpression of serotonin4 receptors in cisapride-responsive adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia causing Cushing's syndrome. J Clin Endocrinol Metab 2003;88:248-254. 10.1210/jc.2002-021107
72. Mannelli M, Ferruzzi P, Luciani P, Crescioli C, Buci L, Corona G, et al. Cushing's syndrome in a patient with bilateral macronodular adrenal hyperplasia responding to cisapride: An in vivo and in vitro study. J Clin Endocrinol Metab 2003;88:4616-4622. 10.1210/jc.2002-021949
73. Yared Z, Antonini S, Lacroix A. Macronodular adrenal hyperplasia with long-term primary hyperaldosteronism and recent cyclical Cushing's syndrome with aberrant response of cortisol to serotonin agonist 5-HT4 R. The Endocrine Society 85th Meeting Philadelphia, PA 2003;P2-568, 445.
74. Contesse V, Reznik Y, Louiset E, Duparc C, Cartier D, Sicard F, et al. Abnormal sensitivity of cortisol-producing adrenocortical adenomas to serotonin: In vivo and in vitro studies. J Clin Endocrinol Metab 2005.
75. Louiset E, Cartier D, Contesse V, Duparc C, Lihrmann I, Young J, et al. Paradoxical inhibitory effect of serotonin on cortisol production from adrenocortical lesions causing Cushing's syndrome. Endocr Res 2004;30:951-954. 10.1081/ERC-200044170
76. Nakamura Y, Son Y, Kohno Y, Shimono D, Kuwamura N, Koshiyama H, et al. Case of adrenocorticotropic hormone-independent macronodular adrenal hyperplasia with possible adrenal hypersensitivity to angiotensin II. Endocrine 2001;15:57-61. 10.1385/ENDO:15:1:057
77. Bertherat J, Contesse V, Louiset E, Barrande G, Duparc C, Groussin L, et al. Abnormal sensitivity of the adrenocortical tissue to multiple stimuli in ACTH-independent macronodular adrenal hyperplasia (AIMAH) causing Cushing's syndrome: In vivo and in vitro studies. The Endocrine Society's 86th Meeting, New Orleans, LO 2004;P3-403, 562.
78. Willenberg HS, Stratakis CA, Marx C, Ehrhart-Bornstein M, Chrousos GP, Bornstein SR. Aberrant interleukin-1 receptors in a cortisol-secreting adrenal adenoma causing Cushing's syndrome. N Engl J Med 1998;339:27-31. 10.1056/NEJM199807023390105
79. Hashimoto K, Kawada Y, Murakami K, Hattori T, Suemaru S, Kageyama J, et al. Cortisol responsiveness to insulin-induced hypoglycemia in Cushing's syndrome with huge nodular adrenocortical hyperplasia. Endocrinol Jpn 1986;33:479-487. 1:STN:280:BiiD1c%2FhvV0%3D
80. Yared Z, Bourdeau I, Lacroix A. Failure to control Cushing's syndrome with leuprolide acetate in a case of ACTH-independent bilateral macronodular adrenal hyperplasia with partial regulation of cortisol secretion by LH and hCG. The Endocrine Society 84th Meeting. San Francisco, CA 2002;649.
81. Lefebvre H, Duparc C, Chartrel N, Jegou S, Pellerin A, Laquerriere A, et al. Intraadrenal adrenocorticotropin production in a case of bilateral macronodular adrenal hyperplasia causing Cushing's syndrome. J Clin Endocrinol Metab 2003;88:3035-3042. 10.1210/jc.2002-030014
82. Lacroix A, Mircescu H, Hamet P. Clinical evaluation of the presence of abnormal hormone receptors in adrenal Cushing's syndrome. The Endocrinologist 1999;9:9-15.
83. Reznik Y, Lefebvre H, Rohmer V, et al. Aberrant sensitivity to multiple ligands in unilateral adrenal incidentaloma: A prospective study. Clin Endocrinol (Oxf) 2004;61:311-319. 10.1111/j.1365-2265.2004.02048.x
84. Bertherat J, Barrande G, Lefebvre H, et al. Illegitimate membrane receptors are frequent and often multiple in bilateral ACTH-independent macronodular adrenal hyperplasia. The Endocrine Society 85th Meeting. Philadelphia, PA 2003;P3-410, 570.
85. Bertherat J, Contesse V, Louiset E, Barrande G, Duparc C, Groussin L, et al. In vivo and in vitro screening for illegitimate receptors in ACTH-independent macronodular adrenal hyperplasia (AIMAH) causing cushing's syndrome: Identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism. J Clin Endocrinol Metab 2004.
86. Dall'Asta C, Ballare E, Mantovani G, Ambrosi B, Spada A, Barbetta L, et al. Assessing the presence of abnormal regulation of cortisol secretion by membrane hormone receptors: In vivo and in vitro studies in patients with functioning and non-functioning adrenal adenoma. Horm Metab Res 2004;36:578-583. 10.1055/s-2004-825797
87. Tatsuno I, Uchida D, Tanaka T, Koide H, Shigeta A, Ichikawa T, et al. Vasopressin responsiveness of subclinical Cushing's syndrome due to ACTH-independent macronodular adrenocortical hyperplasia. Clin Endocrinol (Oxf) 2004;60:192-200. 10.1046/j.1365-2265.2003.01963.x
88. Farfel Z, Bourne HR, Iiri T. The expanding spectrum of G protein diseases. N Engl J Med 1999;340:1012-1020. 10.1056/NEJM199904013401306
89. Bourdeau I, D'Amour P, Hamet P, Boutin J-M, Lacroix A. Abberant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome. J Clin Endocrinol Metab 2001;86:5534-5540. 10.1210/jc.86.11.5534
90. Bourdeau I, Antonini S, Lacroix A, Kirschner LS, Lorang D, Libutti SK, et al. Gene array analysis of macronodular adrenal hyperplasis confirms clinical heterogenity and identifies several genes as molecular mediators. Oncogene 2004;26:1575-1585
91. Gicquel C, Bertagna X, Le Bouc Y. Recent advances in the pathogenesis of adrenocortical tumours. Eur J Endocrinol 1995;133:133-144. 1:CAS:528:DyaK2MXnsFGjsLc%3D
92. Diaz-Cano SJ, de Miguel M, Blanes A, Tashjian R, Galera H, Wolfe HJ. Clonality as expression of distinctive cell kinetics patterns in nodular hyperplasias and adenomas of the adrenal cortex. Am J Pathol 2000;156:311-319. 1:STN:280:DC%2BD3c%2FptVGktA%3D%3D
93. Beuschlein F, Reincke M, Karl M, Travis WD, Jaursch-Hancke C, Abdelhamid S, et al. Clonal composition of human adrenocortical neoplasms. Cancer Res 1994;54:4927-4932. 1:CAS:528:DyaK2cXlslKntrg%3D
94. Gicquel C, Leblond-Francillard M, Bertagna X, Louvel A, Chapuis Y, Luton JP, et al. Clonal analysis of human adrenocortical carcinomas and secreting adenomas. Clin Endocrinol (Oxf) 1994;40:465-477. 1:STN:280:ByuB2cvgslw%3D
95. Antonini SR, N'Diaye N, Baldacchino V, Hamet P, Tremblay J, Lacroix A. Analysis of the putative regulatory region of the gastric inhibitory polypeptide receptor gene in food-dependent Cushing's syndrome. J Steroid Biochem Mol Biol 2004;91:171-177. 10.1016/j.jsbmb.2004.03.120
96. Baldacchino V, Oble S, Hamet P, Tremblay J, Lacroix A. Partial characterisation of the 5' flanking region of the human GIP receptor (GIPR) gene. Endocr Res 2002;28:577. 10.1081/ERC-120016843
97. Findlay JC, Sheeler LR, Engeland WC, Aron DC. Familial adrenocorticotropin-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia. J Clin Endocrinol Metab 1993;76:189-191. 10.1210/jc.76.1.189
98. Minami S, Sugihara H, Sato J, Tatsukuchi A, Sugisaki Y, Sasano H, et al. ACTH independent Cushing's syndrome occurring in siblings. Clin Endocrinol (Oxf) 1996;44:483-488. 10.1046/j.1365-2265.1996.682504.x
99. Nies C, Bartsch DK, Ehlenz K, Wild A, Langer P, Fleischhacker S, et al. Familial ACTH-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia clinically affecting only female family members. Exp Clin Endocrinol Diabetes 2002;110:277-283. 10.1055/s-2002-34590
100. Kero J, Poutanen M, Zhang FP, Rahman N, McNicol AM, Nilson JH, et al. Elevated luteinizing hormone induces expression of its receptor and promotes steroidogenesis in the adrenal cortex. J Clin Invest 2000;105:633-641. 1:CAS:528:DC%2BD3cXhslygsbk%3D
101. Swords FM, Aylwin S, Perry L, Arola J, Grossman AB, Monson JP, et al. The aberrant expression of the gastric inhibitory polypeptide (GIP) receptor in adrenal hyperplasia: Does chronic ACTH exposure stimulate up-regulation of GIP receptors in Cushing's disease? J Clin Endocrinol Metab 2005.
102. Sturrock ND, Morgan L, Jeffcoate WJ. Autonomous nodular hyperplasia of the adrenal cortex: Tertiary hypercortisolism? Clin Endocrinol (Oxf) 1995;43:753-758. 1:STN:280:BymB1MjitFE%3D
103. Hocher B, Bahr V, Dorfmuller S, Oelkers W. Hypercortisolism with non-pigmented micronodular adrenal hyperplasia: Transition from pituitary-dependent to adrenal-dependent Cushing's syndrome. Acta Endocrinol (Copenh) 1993;128:120-125. 1:STN:280:ByyC1MfkvVQ%3D
104. Choi Y, Werk EE Jr, Sholiton LJ. Cushing's syndrome with dual pituitary-adrenal control. Arch Intern Med 1970;125:1045-1049. 10.1001/ archinte.125.6.1045
105. Aron DC, Findling JW, Fitzgerald PA, Brooks RM, Fisher FE, Forsham PH, et al. Pituitary ACTH dependency of nodular adrenal hyperplasia in Cushing's syndrome. Report of two cases and review of the literature. Am J Med 1981;71:302-306. 10.1016/0002-9343(81)90132-7